Mitral valve abnormalities identified by cardiovascular magnetic resonance represent a primary phenotypic expression of hypertrophic cardiomyopathy | Circulation | 2011 | 251 |
down-regulation of Kruppel-like factor-4 (KLF4) by microRNA-143/145 is critical for modulation of vascular smooth muscle cell phenotype by transforming growth factor-beta and bone morphogenetic protein 4 | Journal of Biological Chemistry | 2011 | 205 |
Micromanaging vascular smooth muscle cell differentiation and phenotypic modulation | Arteriosclerosis, Thrombosis, and Vascular Biology | 2011 | 164 |
Acquired long QT syndrome from stress cardiomyopathy is associated with ventricular arrhythmias and torsades de pointes | Heart Rhythm | 2011 | 141 |
Hypoxia potentiates microRNA-mediated gene silencing through posttranslational modification of Argonaute2 | Molecular and Cellular Biology | 2011 | 107 |
Heart failure with preserved ejection fraction | Circulation | 2011 | 91 |
Cardiac resynchronization therapy reduces left atrial volume and the risk of atrial tachyarrhythmias in MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy) | Journal of the American College of Cardiology | 2011 | 78 |
A multicenter, randomized, double-blind, placebo-controlled study of tolvaptan monotherapy compared to furosemide and the combination of tolvaptan and furosemide in patients with heart failure and systolic dysfunction | Journal of Cardiac Failure | 2011 | 73 |
Aldosterone regulates vascular gene transcription via oxidative stress-dependent and -independent pathways | Arteriosclerosis, Thrombosis, and Vascular Biology | 2011 | 68 |
Management of HeartWare left ventricular assist device thrombosis using intracavitary thrombolytics | Journal of Thoracic and Cardiovascular Surgery | 2011 | 63 |
Bivalirudin is a dual inhibitor of thrombin and collagen-dependent platelet activation in patients undergoing percutaneous coronary intervention | Circulation: Cardiovascular Interventions | 2011 | 51 |
Augmentation index derived from peripheral arterial tonometry correlates with cardiovascular risk factors | Cardiology Research and Practice | 2011 | 50 |
Incidence and significance of pacemaker and implantable cardioverter-defibrillator lead masses discovered during transesophageal echocardiography | PACE - Pacing and Clinical Electrophysiology | 2011 | 48 |
Direct vasorelaxation by a novel phytoestrogen tanshinone IIA is mediated by nongenomic action of estrogen receptor through endothelial nitric oxide synthase activation and calcium mobilization | Journal of Cardiovascular Pharmacology | 2011 | 46 |
Associations of edge-detected and manual-traced common carotid intima-media thickness measurements with Framingham risk factors: the multi-ethnic study of atherosclerosis | Stroke | 2011 | 45 |
Pressure-volume relationships in patients with transthyretin (ATTR) cardiac amyloidosis secondary to V122I mutations and wild-type transthyretin: Transthyretin Cardiac Amyloid Study (TRACS) | Circulation: Heart Failure | 2011 | 44 |
Novel inactivating mutations in the GH secretagogue receptor gene in patients with constitutional delay of growth and puberty | European Journal of Endocrinology | 2011 | 42 |
MicroRNA expression data reveals a signature of kidney damage following ischemia reperfusion injury | PLoS ONE | 2011 | 41 |
Differential cardioprotective effects of salvianolic acid and tanshinone on acute myocardial infarction are mediated by unique signaling pathways | Journal of Ethnopharmacology | 2011 | 39 |
Drug and device effects on peak oxygen consumption, 6-minute walk distance, and natriuretic peptides as predictors of therapeutic effects on mortality in patients with heart failure and reduced ejection fraction | Circulation: Heart Failure | 2011 | 31 |
ANGPTL4 variants E40K and T266M are associated with lower fasting triglyceride levels in Non-Hispanic White Americans from the Look AHEAD Clinical Trial | BMC Medical Genetics | 2011 | 30 |
Autopsy validation study of the academic research consortium stent thrombosis definition | JACC: Cardiovascular Interventions | 2011 | 30 |
Effects of tolvaptan on physician-assessed symptoms and signs in patients hospitalized with acute heart failure syndromes: analysis from the efficacy of vasopressin antagonism in heart failure outcome study with tolvaptan (EVEREST) trials | American Heart Journal | 2011 | 29 |
Transforming growth factor-β: governing the transition from inflammation to fibrosis in heart failure with preserved left ventricular function | Circulation: Heart Failure | 2011 | 28 |
Smad-mediated miRNA processing: a critical role for a conserved RNA sequence | RNA Biology | 2011 | 25 |